EUVIMEDEUVIMED entdecken
Crossref

IgA Nephropathy: Current Treatment Strategies and Perspectives on Targeted Therapy

Gulnar Chingayeva, Dina Karibayeva, Assel Issenova, Abay Shepetov, Nagima Mustapayeva, Nazym Nigmatullina, Kairat Kabylbayev, Elmira Alimzhanova, Marzhan Shepetova, Zhadira Abiyeva, Zhuldyz Baidauletova, Nazym Dauletbayeva und 1 weitere

Central Asian Journal of Nephrology · 02.04.2026 · 2 (1) · cajn013

DOI: 10.63946/cajn/18302 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Central Asian Journal of Nephrology, erschienen am 02.04.2026. Verfasst von Gulnar Chingayeva und 12 weiteren Autor:innen. Die Arbeit nennt 82 Literaturangaben.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Immunoglobulin A nephropathy is among the most commonly observed glomerular disorders. Its development is associated with immune dysfunction, which initiates a cascade of pathological changes within the glomeruli. The clinical course can range from minimal urinary abnormalities to progressive renal impairment, potentially culminating in end-stage kidney disease. Despite considerable advances in understanding its pathogenesis, optimal therapeutic strategies remain an active focus of scientific investigation.

Aim

To assess current and emerging therapeutic strategies for IgA nephropathy, with an emphasis on efficacy, safety, and the potential of targeted agents addressing key pathogenic pathways.

Methods

We conducted a narrative review of recent literature in PubMed, Scopus, Web of Science, and eLIBRARY databases, focusing on publications from the last decade. Studies published in English and Russian that reported results from clinical trials or meta-analyses on therapeutic interventions for IgA nephropathy were included. Search terms included «IgA nephropathy», «treatment», «targeted therapy», «new therapies», «immunosuppressants», and «clinical trials». Priority was given to randomized controlled trials and studies with high-quality evidence, though relevant observational data were also considered.

Results

Key studies identified included 52 publications, among which 20 were randomized clinical trials and a systematic review. Corticosteroid therapy remains a cornerstone of treatment but is limited by significant adverse effects. Recent therapeutic developments in IgA nephropathy have focused on interventions that selectively target inflammatory and immune pathways involved in disease progression. Certain novel agents aimed at modulating immune signaling or addressing pathogenic plasma cells have shown potential to reduce proteinuria and stabilize renal function. Early-phase clinical investigations indicate promising efficacy and manageable safety profiles, suggesting these approaches may represent important advances in disease management.

Conclusions

Recent progress in targeted and immunomodulatory therapies offers new perspectives for personalized treatment of IgA nephropathy. Comprehensive, large-scale randomized studies with extended follow-up are warranted to thoroughly assess the therapeutic potential, safety profile, and optimal positioning of these interventions within future clinical management strategies.

Zitieren

APA

Chingayeva, G., Karibayeva, D., Issenova, A., Shepetov, A., Mustapayeva, N., Nigmatullina, N., Kabylbayev, K., Alimzhanova, E., Shepetova, M., Abiyeva, Z., Baidauletova, Z., Dauletbayeva, N., & Yespotayeva, A. (2026). IgA Nephropathy: Current Treatment Strategies and Perspectives on Targeted Therapy. Central Asian Journal of Nephrology, 2(1), cajn013. https://doi.org/10.63946/cajn/18302

Vancouver

Chingayeva G, Karibayeva D, Issenova A, Shepetov A, Mustapayeva N, Nigmatullina N, et al. IgA Nephropathy: Current Treatment Strategies and Perspectives on Targeted Therapy. Central Asian Journal of Nephrology. 2026;2(1):cajn013. doi:10.63946/cajn/18302

BibTeX
@article{Chingayeva2026,
  author = {Chingayeva, Gulnar and Karibayeva, Dina and Issenova, Assel and Shepetov, Abay and Mustapayeva, Nagima and Nigmatullina, Nazym and Kabylbayev, Kairat and Alimzhanova, Elmira and Shepetova, Marzhan and Abiyeva, Zhadira and Baidauletova, Zhuldyz and Dauletbayeva, Nazym and Yespotayeva, Arina},
  title = {IgA Nephropathy: Current Treatment Strategies and Perspectives on Targeted Therapy},
  journal = {Central Asian Journal of Nephrology},
  year = {2026},
  volume = {2},
  number = {1},
  pages = {cajn013},
  doi = {10.63946/cajn/18302}
}
Kostenlos starten →